Mechanism and efficacy of sub-50 nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma

Improved survival for HNC patients with recurrent and metastatic disease warrants that cancer therapy is specific with protected delivery of the therapeutic agent to primary and metastatic cancer cells. A further objective should be that downregulation of the intracellular therapy target leads to ce...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Unger, Gretchen M., Kren, Betsy T., Korman, Vicci L., Kimbrough, Tyler G., Vogel, Rachel I., Ondrey, Frank G., Trembley, Janeen H., Ahmed, Khalil
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2014
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4126856/
https://ncbi.nlm.nih.gov/pubmed/24867250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-14-0166
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk